Innovative Research Award
| Tayyab Ali Asif |
| Affiliation |
Henan Agricultural University |
| Country |
China |
| Scopus ID |
57223959800 |
| Documents |
3 |
| Citations |
29 |
| h-index |
2 |
| Subject Area |
Vaccinology |
| Event |
International Research Hypothesis Excellence Award |
| ORCID |
0009-0003-5120-3932 |
Tayyab Ali Asif is a researcher affiliated with Henan Agricultural University in Zhengzhou, China, whose published work is associated with vaccinology, viral immunology, and vaccine development. His research record includes studies on adenoviral vaccine candidates and, more recently, nano-adjuvant strategies for infectious bursal disease virus vaccines. [1] [2] [3]
Abstract
Tayyab Ali Asif’s research profile is centered on vaccinology and vaccine-related research, with documented contributions involving adenovirus-based vaccine candidates and infectious bursal disease virus (IBDV). His recent review in Frontiers in Immunology examines nano-adjuvant platforms, including lipid nanoparticles, polymeric systems, virosomes, mesoporous silica, polysaccharides, and nanoemulsions, in the context of improving vaccine immunogenicity, stability, delivery, and immune responses. [1] Earlier publications examined protective epitopes and an adenovirus capsid insertion domain as potential vaccine components. [2] [3]
Keywords
Keywords: vaccinology; vaccine development; viral immunology; infectious bursal disease virus; IBDV vaccines; nano-adjuvants; adenovirus vaccines; vaccine candidates; immunogenicity; poultry health.
Introduction
Vaccinology encompasses the development, evaluation, and optimization of vaccines and associated technologies for preventing infectious diseases. Within veterinary vaccinology, poultry diseases present important scientific and production challenges, including infectious bursal disease caused by IBDV. Research into antigen selection, vaccine platforms, delivery systems, and immune modulation is therefore relevant to the development of improved preventive strategies. [1]
Asif’s documented publications span multiple aspects of vaccine research. A 2021 study investigated conserved epitopes on adenovirus hexon proteins and evaluated their potential as vaccine candidates, while a 2022 study examined an insertion domain of the fowl adenovirus type 4 penton base protein. [2] [3] In 2026, his research activity included a comprehensive review of nano-adjuvants and their prospective applications in IBDV vaccination. [1]
Research Profile
Asif is affiliated with the College of Veterinary Medicine at Henan Agricultural University in Zhengzhou, China. Publicly indexed research records identify his work in the area of veterinary and viral vaccinology. [1] His author profile is also associated with research on adenoviruses and vaccine candidates, reflecting a research trajectory connecting viral antigen characterization with vaccine development.
Research Contributions
A notable area of Asif’s published research concerns the identification and evaluation of viral protein regions as potential vaccine components. The 2021 Vaccine article investigated potent epitopes on the hexon capsid protein of adenoviruses and assessed their vaccine-candidate potential. [2]
The 2022 Microbial Pathogenesis study examined the insertion domain of the penton base protein from fowl adenovirus type 4. The study reported production of the domain in soluble form and evaluated its protective properties in the context of fowl adenovirus infection, providing research evidence relevant to subunit vaccine development. [3]
The 2026 review extends this research direction toward vaccine formulation and delivery by examining nano-adjuvants for IBDV vaccines. The review discusses how different nano-based platforms may influence antigen delivery, immunogenicity, cellular and humoral immune responses, and vaccine safety. [1]
Publications
- Asif, T. A., Ji, P., Qiao, X., Yang, Q., Jiang, D., & Zhang, G. (2026). Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. Frontiers in Immunology, 17, 1805229. DOI: 10.3389/fimmu.2026.1805229. [1]
- Tufail, S., Shah, M. A., Zafar, M., Asif, T. A., et al. (2021). Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family. Vaccine, 39(27), 3560–3564. DOI: 10.1016/j.vaccine.2021.05.023. [2]
- Tufail, S., Shah, M. A., Asif, T. A., et al. (2022). Highly soluble and stable ‘insertion domain’ of the capsid penton base protein provides complete protection against infections caused by fowl adenoviruses. Microbial Pathogenesis, 173, 105835. DOI: 10.1016/j.micpath.2022.105835. [3]
Research Impact
The supplied research profile records 3 documents, 29 citations, and an h-index of 2. These bibliometric figures provide a quantitative snapshot of the indexed research record and may change as databases are updated. The publications themselves demonstrate engagement with vaccine-antigen discovery, adenovirus vaccine research, and emerging nano-adjuvant approaches for veterinary vaccines. [1] [2] [3]
The 2026 review is particularly relevant to contemporary vaccine research because it brings together several nano-adjuvant platforms and discusses their possible roles in antigen delivery and immune stimulation. The authors identify areas requiring continued investigation, including antigen selection, delivery strategies, immune modulation, safety, and broader protection against IBDV variants. [1]
Award Suitability
For the International Research Hypothesis Excellence Award, the documented research record provides several areas that can be considered during an academic recognition review. These include publication activity in peer-reviewed journals, a defined research focus in vaccinology, work involving vaccine candidate antigens, and participation in research addressing vaccine formulation and delivery. [1] [2] [3]
Any formal award determination should be based on the applicable award criteria, verified researcher information, publication records, and supporting documentation rather than bibliometric indicators alone. The information presented here describes the publicly documented research profile and does not constitute an independent assessment of award outcome.
Conclusion
Tayyab Ali Asif’s documented research activity is associated with vaccinology, viral immunology, and vaccine development. His publications include investigations of adenoviral epitopes and vaccine-related protein domains, followed by a 2026 review examining nano-adjuvant technologies for IBDV vaccines. [1] [2] [3] Together, these publications provide a documented basis for describing his research interests within veterinary vaccinology and related vaccine sciences.
External Links
References
- Asif, T. A., Ji, P., Qiao, X., Yang, Q., Jiang, D., & Zhang, G. (2026). Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. Frontiers in Immunology, 17, 1805229.
DOI: https://doi.org/10.3389/fimmu.2026.1805229
PubMed record
- Tufail, S., Shah, M. A., Zafar, M., Asif, T. A., et al. (2021). Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family. Vaccine, 39(27), 3560–3564.
DOI: https://doi.org/10.1016/j.vaccine.2021.05.023
PubMed record
- Tufail, S., Shah, M. A., Asif, T. A., et al. (2022). Highly soluble and stable ‘insertion domain’ of the capsid penton base protein provides complete protection against infections caused by fowl adenoviruses. Microbial Pathogenesis, 173, 105835.
DOI: https://doi.org/10.1016/j.micpath.2022.105835
PubMed record